Oppenheimer Sees 'Significant Upside Potential' In PTC Therapeutics
February 25, 2016 at 10:47 AM EST
Oppenheimer’s Christopher Marai maintained an Outperform rating for PTC Therapeutics, Inc. (NASDAQ: PTCT), while reducing the ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.